Related Experiment Video

Updated: Apr 18, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.8K

Correction: Peptide‑based therapeutics targeting the SLC39A14‑PIWIL2 fusion in hepatocellular carcinoma

Masaud Shah1, Sung Ung Moon1, Ji-Hye Choi1,2

  • 1Department of Physiology, Ajou University School of Medicine, Suwon, 16499, Republic of Korea.

Genomics & Informatics
|April 17, 2026
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.6K
Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

8.4K

Related Experiment Videos

Last Updated: Apr 18, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.8K
Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.6K
Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

8.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K

Articles linked to this work by shared authors, journal, and citation graph.

Engineered flower-like core-double-shell upconversion nanoarchitectures for ultrasensitive activatable FRET imaging of cathepsin B in vitro and in vivo.

Talanta·2026

Enhanced multicancer screening assay through whole-genome methylation sequencing-based multimodal cell-free DNA analysis.

Experimental & molecular medicine·2026

Differential MicroRNA Expression in Chronic Spontaneous Urticaria in Relation to Treatment Response.

Allergy, asthma & immunology research·2026

Distinct Serum MicroRNA Signatures and mRNA Decay Pathway Dysregulation in NSAID-Exacerbated Chronic Urticaria.

International journal of molecular sciences·2026

Mitochondrial transfer in cancer: mechanisms, immune evasion, and therapeutic opportunities.

Genomics & informatics·2026

Resolution of Noncardiogenic Pulmonary Oedema and Suspected Uraemic Pneumonitis in a Dog With Acute Kidney Injury Treated by Haemodialysis.

Veterinary medicine and science·2026

Pre-sampling conditions affect salivary genomic DNA yield and human DNA fraction: a single-donor pilot study.

Genomics & informatics·2026

Exploratory strain-associated patterns of antiviral transcriptional responses to Zika virus exposure in developing human neural tissue.

Genomics & informatics·2026

Design of a multi-epitope vaccine against Mycobacterium tuberculosis using reverse vaccinology and immunoreactive peptides.

Genomics & informatics·2026

Precision Medicine Gene Network Analyser: part I-cancer driver gene identification through network topology and ensemble machine learning.

Genomics & informatics·2026

A bioinformatics pipeline for the design of a SART3-targeted cancer vaccine with enhanced immunogenicity.

Genomics & informatics·2026

Measuring the gap: correlating synthetic-to-real drift with PHI de-identification performance.

Genomics & informatics·2026

GATA1 knockdown enhances CD8+ T cell responses and protects against immune escape in cervical squamous cell carcinoma through FGL1 downregulation.

Journal of molecular histology·2026

Tolerability of [161Tb]Tb-SibuDAB in comparison to other PSMA-targeting radioligands in the preclinical setting.

European journal of nuclear medicine and molecular imaging·2026

Efficacy and safety of adjuvant CDK4/6 inhibitors in hormone receptor-positive, HER2-negative early breast cancer: Updated evidence from a systematic review and meta-analysis.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Decision-to-outcome analysis of multidisciplinary tumor board-managed NSCLC patients.

Turk gogus kalp damar cerrahisi dergisi·2026

Electronic Structure Engineering at C7 Position of Thieno-Cytosine (thC): Toward Optimal Probe-Adduct Interactions with ABPG in DNA.

The journal of physical chemistry. B·2026

How Functional Variants Reconfigure the Rac2 Conformational Landscape.

The journal of physical chemistry. B·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us